✦ LIBER ✦

Antiviral drugs: Macrocyclic inhibitor for hepatitis C

✍ Scribed by Brazil, Melanie

Book ID: 109949382
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 109 KB
Volume: 2
Category: Article
ISSN: 1474-1776
DOI: 10.1038/nrd1259

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antiviral therapy for hepatitis C

✍ Michelle M. Lipman; Scott J. Cotler 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 350 KB

Antiviral drug resistance in hepatitis B

Antiviral drug resistance in hepatitis B and C

✍ STEPHEN A LOCARNINI; TIM SHAW 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

New antiviral therapies for chronic hepa

New antiviral therapies for chronic hepatitis C

✍ Tatsuo Kanda; Fumio Imazeki; Osamu Yokosuka 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 387 KB

Specific targeted antiviral therapy for

Specific targeted antiviral therapy for hepatitis C

✍ Mark S. Sulkowski 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 207 KB

Hepatitis C virus experimental model sys

Hepatitis C virus experimental model systems and antiviral drug research

✍ Susan L. Uprichard 📂 Article 📅 2010 🏛 SP Wuhan Institute of Virology, CAS 🌐 English ⚖ 787 KB

Cost-effectiveness of hepatitis C virus

Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populations

✍ Natasha K. Martin; Peter Vickerman; Alec Miners; Graham R. Foster; Sharon J. Hut 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 291 KB 👁 1 views

Injecting drug use is the main risk of hepatitis C virus (HCV) transmission in most developed countries. HCV antiviral treatment (peginterferon-a 1 ribavirin) has been shown to be costeffective for patients with no reinfection risk. We examined the cost-effectiveness of providing antiviral treatment